CRF Connect Logo
  • Tracks & Learning Series
    VIEW ALL
  • Conferences
  • My Favorites

Coronary

Clinical Indications and Science Learning Series

ACS and Primary PCI

Coronary >
ACS and Primary PCI

Episodes

Refractory Cardiogenic Shock With Severe LV Dysfunction and a Mechanical Complication of Inferior Wall MI

Refractory Cardiogenic Shock With Severe LV Dysfunction and a Mechanical Complication of Inferior Wall MI

13 min.

Unloading in AMI:  Changing the Paradigm from DTB to DTU

Unloading in AMI: Changing the Paradigm from DTB to DTU

9 min.

How Important Is Complete Revascularization?

How Important Is Complete Revascularization?

7 min.

For Most Patients, Only Spontaneous MI Is Relevant

For Most Patients, Only Spontaneous MI Is Relevant

6 min.

Management of High Thrombus Burden in STEMI

Management of High Thrombus Burden in STEMI

8 min.

STEMI and MVD Update on the Evidence: Rationale for COMPLETE 2

STEMI and MVD Update on the Evidence: Rationale for COMPLETE 2

8 min.

STEMI with Multivessel Disease: Managing the Non-Culprit Vesel

STEMI with Multivessel Disease: Managing the Non-Culprit Vesel

3 min.

Case Presentation:  Managing the Non-Culprit Vessel in STEMI with Multivessel Disease:

Case Presentation: Managing the Non-Culprit Vessel in STEMI with Multivessel Disease:

4 min.

ACS with a Large Thrombus Burden: Thrombectomy Revisited ? Guidelines Recommendations

ACS with a Large Thrombus Burden: Thrombectomy Revisited ? Guidelines Recommendations

3 min.

Thrombectomy Case Presentation

Thrombectomy Case Presentation

5 min.

TCT 688: An Unfortuante Trifecta: A case of  acute myocardial infarction with cardiogenic shock, pericardial tamponade, and worsening hypoxia with right to left shunt after percutaneous LVAD placement.

TCT 688: An Unfortuante Trifecta: A case of  acute myocardial infarction with cardiogenic shock, pericardial tamponade, and worsening hypoxia with right to left shunt after percutaneous LVAD placement.

6 min.

TCT 640: POST MYOCARDIAL INFARCTION VENTRICULAR SEPTAL RUPTURE WITH HEART FAILURE AND CARDIOGENIC SHOCK : CHALLENGES AND DEVICE CLOSURE

TCT 640: POST MYOCARDIAL INFARCTION VENTRICULAR SEPTAL RUPTURE WITH HEART FAILURE AND CARDIOGENIC SHOCK : CHALLENGES AND DEVICE CLOSURE

6 min.

TCT 659: Acute Mitral Regurgitation With Unilateral Left-Sided Pulmonary Edema: A Complication of STEMI Treated Successfully With A Mitra-Clip Procedure

TCT 659: Acute Mitral Regurgitation With Unilateral Left-Sided Pulmonary Edema: A Complication of STEMI Treated Successfully With A Mitra-Clip Procedure

6 min.

Periprocedural MI Matters to All Patients!

Periprocedural MI Matters to All Patients!

4 min.

Should We Be Stenting All Patients Presenting With STEMI? Pros and Cons

Should We Be Stenting All Patients Presenting With STEMI? Pros and Cons

8 min.

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

8 min.

New and Emerging Pharmacology for ACS: Factor XI Inhibition

New and Emerging Pharmacology for ACS: Factor XI Inhibition

6 min.

State-of-the Art: Top 10 Lessons We Have Learned In ACS Management

State-of-the Art: Top 10 Lessons We Have Learned In ACS Management

12 min.

Short DAPT or De-Escalation After ACS

Short DAPT or De-Escalation After ACS

7 min.

P2Y12 Inhibitors in ACS: Which Agent in Which Patient and When?

P2Y12 Inhibitors in ACS: Which Agent in Which Patient and When?

7 min.

Hemodynamic Support for High-Risk PCI in ACS

Hemodynamic Support for High-Risk PCI in ACS

8 min.

PCI in STEMI - Never Treat the Non-Culprit in the Same Setting

PCI in STEMI - Never Treat the Non-Culprit in the Same Setting

3 min.

Management of No-Reflow in ACS

Management of No-Reflow in ACS

2 min.

PCI in STEMI -  Complete Revascularization As Long As You Can Manage the Contrast/Hemodynamics

PCI in STEMI - Complete Revascularization As Long As You Can Manage the Contrast/Hemodynamics

4 min.

This website uses cookies to ensure you get the best experience on our website. Read More